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Abstract. Potocytosis is an endocytic pathway that 
utilizes glycosylphosphatidylinositol-anchored mem- 
brane proteins and caveolae to concentrate and inter- 
nalize small molecules. We now report that activators 
of protein kinase C  are potent inhibitors of potocyto- 
sis.  Activators such as phorbol-12-myristate-13-acetate 
(PMA) inhibit the internalization of receptors for 
5-methyltetrahydrofolate but allow the internal receptor 
pool to return to the cell surface. PMA does not affect 
the clustering of the folate receptor but instead 
markedly reduces the number of caveolae. Exposure to 
PMA totally blocks the intracellular accumulation of 
5-methyltetrahydrofolate without affecting receptor- 
independent uptake or the formation of polyglutamy- 
lated species of 5-methyltetrahydrofolate in the cyto- 
plasm.  These data suggest that PMA inhibits uptake 
by inactivating caveolae internalization. 
C 
ELLS concentrate and take up low molecular weight 
molecules by potocytosis (5,  6).  The best  studied 
example of this endocytic process  is the receptor- 
mediated  uptake  of  5-methyltetrahydrofolate in  MA104 
cells. Morphological (28, 29) and biochemical (19-22) ex- 
periments have shown that this vitamin is delivered to the 
cell interior after binding to a glycosylphosphatidylinositol 
(GPI)t-achored membrane receptor that is concentrated in 
caveolae. The receptor-folate complex is then sequestered 
within closed caveolae. After the caveolae seal off from the 
extracellular space, the folate dissociates from the receptor 
and diffuses through a membrane carder into the cytoplasm 
(21).  The vitamin becomes polyglutamylated as soon as it 
reaches the cytoplasm, which prevents diffusion out of the 
cell. Finally, the closed caveolae open to expose the recep- 
tors for another round of folate uptake. 
Evidence is beginning to accumulate that caveolae are not 
only a membrane vehicle for potocytosis; they also appear 
to play an important role in coordinating the receipt and the 
transmission of cellular messages. A number of molecules 
that have previously been implicated in several different cel- 
lular signaling cascades are being found associated with cav- 
eolae.  These  molecules  include:  an  ATP-dependent  Ca  :+ 
pump (11); a form of the inositol 1,4,5-trisphosphate (IP~)- 
sensitive,  Ca  2÷  channel  (12);  members  of the  src  kinase 
family of nonreceptor tyrosine kinases (32);  heterotrimeric 
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GTP-binding proteins (32);  5"nucleotidase, an enzyme in- 
volved in the production of the signaling molecule, adeno- 
sine  (10); and  inositolphosphoglycans  (30).  The  space 
created each time a caveolae closes is a special environment 
where these molecules may generate or transmit messages. 
There are other indications that caveolae are involved in 
cell signaling. A critical substrate for the transforming activ- 
ity of pp60  '~ kinase is caveolin (13, 15),  a major integral 
membrane protein of caveolae (14, 27). The function of cav- 
eolin is still not known. Most likely caveolae are functionally 
dependent on this protein so that phosphorylation interferes 
with some aspect of the internalization cycle.  Therefore, 
there is a  strong correlation between cell transformation, 
which involves the disruption of normal cell signaling path- 
ways, and impaired caveolae function as a consequence of 
caveolin phosphorylation. 
One way to further define the role of caveolae in potocyto- 
sis and cell signaling is to find reagents that inhibit caveolae 
function. Therefore, we used the folate internalization assay 
developed for MA104 cells (19) to identify reagents that pre- 
vent vitamin uptake. We found that activators of protein ki- 
nase C (PKC) are potent inhibitors of potocytosis because 
they prevent the internalization of caveolae. Caveolae were 
inactivated  by  phorbol-12-myristate-13-acetate  (PMA)  in 
several different cell types, which suggests that this mem- 
brane specialization is a general target for PKC. 
Materials and Methods 
Materials 
Medium 199 with Earle's salts with and without folic acid was prepared in 
the laboratory by standard protocols. Glutamine, trypsin-EDTA,  and poni- 
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serum was from Hazleton  Research Products, Inc. (Lenexa, KS). Antibod- 
ies were obtained  from the following  sources: anti-caveolin  IgG (monoclo- 
nal No. 2234) was a gift from Dr. John Glermey  (Glenteeh  Inc., Lexington, 
KY); rat anti-Thy-1  IgG was prepared from the tissue culture supernatant 
of hybridoma  cells 30-H12 (TIB-107;  American  Type  Tissue  Culture);  rab- 
bit anti-rat IgG was from Sigma  (St. Louis, Me); goat anti-rabbit  IgG con- 
jugated to gold (10 nm) was from Biocell  (Ted Pella, Redding,  CA), mouse 
anti-dinitmphenol  IgG was from Oxford Biomedical (Oxford, MI), goat 
anti-mouse IgG conjugated to gold (10 nm) was  from Energy Beam 
Sciences (Agawam, MA). [3H]folic acid (sp act 27 Ci/mmol) and L-5- 
methyl[3H]tetrahydrofolic acid (sp act 21 Ci/mmol)  were purchased from 
Moravek Biochemicals  (City of Industry,  CA). All PKC activators and in- 
hibitors were purchased from Calbiochem-Novabiochem  (San Diego, CA). 
Probenecid was purchased from Sigma. 
Cell Culture 
MA104 ceils, a monkey kidney epithelial cell line, were grown as a 
monolayer  in folate-free  medium  199 supplemented  with 100 U/ml penicil- 
lin/streptomycin  and 5 % (vol/vol)  fetal calf serum. NIH 3"1"3 cells, a mouse 
fibroblast  cell line, were grown  in Dulbecco's  modified  Eagle's  medium  sup 
plemented with I00 U/ml penicillin/streptomycin  and 5% (vOl/vol)  fetal 
calf serum (34). Cells for each experiment  were set up according  to a stan- 
dard format. On day zero 2.5 ×  105 cells were seeded into a T-25 culture 
flask and grown for 5 d. For binding and uptake studies, medium was 
replaced with M199 without  folate, containing  20 mM Hepes (pH 7.4), and 
additions were made directly to the culture flask (22). 
Folate Binding 
The [3H]folic acid-binding  assay was carried out as previously  described 
(19, 22). MA104  cells were grown for 5 d in low folate medium.  At the be- 
ginning  of the experiment, the cells were washed with PBS and then sub- 
jetted to the indicated experimental  treatment. Following  the treatment, 
cells were chilled on ice for 20 rain and washed twice with ice cold PBS. 
External-bound  folate was the amount  of [3H]folic  acid released  when ceils 
were incubated  on ice for 30 s in the presence of 1.5 ml of acid saline 
(0.15 M Nat1, adjusted  to pH 3.0 with glacial acetic acid). Internal-bound 
folate was the amount  of [~I-l]folic  acid that remained  associated with the 
acid/saline-treated  ceils. The latter was recxwered by adding  0.1 N NaOH 
(15 rain, room temperature) to the flask  to dissolve  the ceils. Radioactivity 
was measured  by liquid scintillation  counting  using  a Tri-carb  1900A liquid 
scintillation  analyzer  (Packard Instruments  Co., Downers  Grove, IL). Non- 
specific binding,  which  was measured  by adding 100-fold  excess unlabeled 
folio acid, was less than 5% of specific binding. 
Immunoelectron Microscopy 
Cells were processed for immunogold  localization  of either the folate  recep- 
•tor or Thy-1 as previously  described (29, 34). 
5-Methyltetrahydrofolate  Acid Internalization 
The 5-methyltetrahydrofolate  internalization  was measured as previously 
described (19, 22). Briefly, at the end of the indicated  incubation  time in 
the presence of 5-methyl[3H]tetrahydrofolate,  ceils were washed with cold 
PBS (4 × 5 ml) before adding 1.5 ml of lysis buffer  (10 mM Tris-HC1, pH 
8.0, 0.02 mg/mi  leupeptin,  0.02 mg/ml  aprotinin,  and I t~M 5-methyltetrahy- 
drofolic acid) to each flask. The flasks were placed at -80°C for 15 rain  2 
and then immediately  thawed on ice. The suspension  was coUected and the 
flask was washed with 1.0 rnl of lysis buffer. The two were combined  and 
centrifuged  for 20 rain at 100,000 g to separate the membrane  (pellet) and  .~,  1.s 
cytoplasmic (supernatant)  fractions. Radioactivity  was measured by liquid 
scintillation  counting.  Nonspecific  binding,  which  was measured  by adding 
100-fold excess unlabeled folio acid to dishes containing radiolabeled  = 
5-methyltetrahydrofolate, was less than 5% of specific binding. 
o.  0. 
Results 
Inhibition of FoUc  Acid Internalization 
Folic acid is a high affinity ligand that remains bound to the 
folate receptor as it travels through the caveolae internaliza- 
tion cycle (22).  MA104 cells incubated in the presence of 
[3H]folic acid at 37°C for  several hours have 50%  of the 
bound folate in an internal, acid-resistant compartment and 
50%  in  an  external,  acid-releasable  compartment.  The 
internal-  and external-bound  folate exchange with each other 
once every hour. A  reagent that inhibits the internalization 
of caveolae should increase the number of external receptors 
while, at the same time, decrease the internal receptor pool. 
The PKC activator PMA was found to have exactly this effect 
(Fig.  1).  We  incubated MA104  cells  in the  presence  of 
various concentrations of PMA for 30 min at 37°C before 
adding [3H]folic acid to  the medium. After an additional 
1 h at 37°C, we measured the internal- and external-bound 
[3H]folic acid.  The lowest concentration of PMA did not 
perturb the normal 1:1 ratio of internal  to external receptors. 
As the concentration of the drug increased, however, there 
was a reciprocal decline in the internal receptor pool and in- 
crease in the external receptor pool.  A  concentration be- 
tween 100 and 500 nM PMA was sufficient to cause a 90% 
shift of [~H]folic acid from the internal to the external frac- 
tion. We choose to use 1 #M PMA for the remaining  experi- 
ments because this was a  concentration that insured com- 
plete  inhibition without  affecting  cell  viability (data  not 
shown). 
The shift of bound folate from the internal to the external 
fraction suggested that PMA did not prevent previously in- 
ternalized receptors from returning to the cell surface. This 
was  confirmed by analyzing the time course of the PMA 
effect. We incubated cells in the presence of 1/~M PMA for 
various times at 37°C,  chilled them to 4°C,  and then in- 
cubated them  for  an additional hour  at 4°C  after  adding 
[3H]folic  acid  to  the  dish.  Fig.  2  shows  the  amount of 
receptor-bound ligand present in the internal and external 
compartments at  each  time point.  As  expected,  pH]folic 
acid was not found in an internal compartment because 4°C 
prevents internalization (Fig. 2, internal). By contrast, be- 
tween 0 and 30 min of exposure to PMA, there was a steady 
increase in the amount of [3H]folic acid that bound to exter- 
nal  receptors  (Fig.  2,  external).  The  amount of  bound 
[3H]folic acid plateaued after 30 min of incubation, indicat- 
ing that virtually all of the receptors had come to the surface. 
Other experiments showed that PMA could be removed after 
as little as 5 min of incubation without affecting the rate at 
which internal receptors appeared at the cell surface. 
We next wanted to see if the receptors that migrated to the 
0 
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Figure  1.  PMA  inhibits the 
binding of  [3H]folic acid  to 
internal receptors (=) while at 
tile same time increasing the 
binding to external  receptors 
(t3).  MA104  cells  were  in- 
cubated in the presence of the 
indicated amount of PMA dis- 
solved in 0.02 % ethanol for 30 
min at 37°C before the addi- 
tion of 5  nM PH]folic  acid. 
Cells were  further incubated 
for 60 min  at 37°C before the amount of radiolabel  present on exter- 
nal and internal receptors waSmeasured.  Each point is the average 
of triplicate  measurements. 
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Figure 2. PMA allows internal  • 1.25  F 
receptors  to come to the cell 
surface  (<>). Cells  were  in- 
cubated  in the presence  of 1 
#M  PMA  for  the  indicated  ~ o.7~  o 
time at 37°C and then chilled 
0.5  to 4°C for 20 min. Cells were 
then incubated for 60 min at  ~ o.25, 
4°C  in the presence of 5 nM 
[3H]folic acid before assaying  ~  0 
for the amount of label bound 
to  internal  (*)  and  external 
(<>) receptors.  Each  point  is 
the average of triplicate trials. Cells that were incubated for 60 min 
at 37°C in the absence of the drug bound 0.81 pmol/mg of protein 
to external receptors while cells incubated in the presence of 1 #M 
of the  inactive  isomer of PMA,  4a-phorbol-12,13-didecanoate, 
bound 0.77 pmol/mg of protein to external receptors. 
surface in response to PMA (Fig. 2) were able to internalize 
[3H]folic acid (Fig.  3).  We incubated ceils in the presence 
(o, •) or absence (zx, A) of 1 #M PMA for 30 min at 37°C 
and then chilled them to 4°C.  We added  [aH]folic acid to 
each dish and incubated the cells for 60 min at 4°C.  After 
the cells were washed, we warmed them to 37°C for the indi- 
cated  time  and  assayed  for  external-  and  internal-bound 
[3H]folic acid.  Initially all of the bound folate in untreated 
cells (A,  ,,) was on external receptors. With time at 37°C, 
there was a steady decline in the external pH]folic acid and 
a corresponding increase in the internal pH]folic acid. The 
internal to external ratio reached 1:1 at 60 min of incubation. 
The PMA-treated cells, by contrast, had nearly 40%  more 
external-bound folate (o) than control cells, which indicates 
that internal receptors came to the surface during the incuba- 
tion.  These receptors did not internalize the vitamin since 
the bound [3H]folic  acid remained constant throughout the 
60-min incubation period (Fig.  3,  o). 
PMA irreversibly activates PKC (18) and causes the down 
regulation of the enzyme within 24 h (35). This explains why 
MA104 cells exposed to PMA for just 5 min were unable to 
internalize pH]folic acid when assayed up to 6 h  after the 
drug was removed (data not shown). We were concerned that 
the lack of reversibility might be due to a nonspecific toxic 
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Figure 3. PMA prevents inter- 
nalization  of bound  [3H]folic 
acid.  Cells were incubated in 
the  presence,  (o,•)  or  ab- 
sence (zx,A) of 1 #M PMA for 
30 min at 37°C and chilled to 
4°C  for 20  min.  Cells  were 
then incubated in the presence 
of 5 nM [3H]folic acid for 60 
min at 4°C,  washed and then 
warmed  to  37°C  in  the  ab- 
sence of [3H]folic acid for the 
indicated time. The amount of 
radiolabel present on external 
(zx,o) and  internal  receptors 
(•,A)  was  measured  as  de- 
scribed. 
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Figure 4. PDBu is a reversible 
inhibitor of folate internaliza- 
tion. Triplicate sets of MA104 
cells  were  incubated  in  the 
presence of  either 1 #M PDBu 
(•)  or  1  #M  PMA  (l)  at 
37°C  for 30  min.  The cells 
were washed to remove the in- 
hibitor and then incubated at 
37°C in fresh media that con- 
tained 5 nM [3H]folic acid for 
the indicated time. At the end 
of the incubation, the ratio of 
internal-  to external-bound  [3H]folic acid  was measured  as de- 
scribed.  Untreated samples had a ratio of 1.02 and  1.04 at 1 and 
4 h, respectively. 
effect of the drug.  For this reason, we tested the reversible 
PKC activator, phorbol-12,  13-dibutyrate (PDBu), to see if 
it inhibited pH]folic acid internalization.  The design of the 
experiment was to incubate cells in the presence of PDBu for 
30 min at 37°C and then wash the cells before adding fresh 
medium and incubating for various times (Fig. 4). At each 
time point,  we measured the  internal to external ratio of 
bound  [3H]folic  acid after a  1-h exposure to the ligand at 
37"C (Fig. 4, •). PDBu was just as effective an inhibitor as 
PMA since both drugs caused a 75 % reduction in the inter- 
nal to external ratio (Fig. 4, compare •  at 4 h with •  on the 
ordinate). After a 1-h incubation in the absence of the drug, 
the ratio began to rise until at 3.5 h a normal ratio of 1:1 was 
observed. These results suggest that activation and deactiva- 
tion of PKC can dramatically affect the caveolar internaliza- 
tion cycle. 
Other Activators of Protein Kinase C 
PMA binds to a conserved region of PKC that is normally 
used by diacylglycerol to regulate the enzyme (18). Homolo- 
gous PMA-binding domains are found in several other pro- 
teins (1, 2, 26), which raises the possibility that PMA may 
sometimes affect cells by binding to molecules other than 
PKC. We tested several other activators of PKC and found 
that they  all were equally  effective at inhibiting  pH]folic 
acid internalization.  For example, 1 #M mezerein caused a 
92 % inhibition of internalization while 1 #M (-) indolactam 
V  inhibited by 80%.  The inactive stereoisomers of PMA 
(4ot-phorbol-12,13 -didecanoate) and ( - ) indolactam V ( [ + ] - 
indolactam V) had no effect. We also found that after an 
overnight incubation in the presence of PMA, which stimu- 
lates the degradation of PKC (35), the inhibition was reduced 
by 80 %. This was unchanged by the addition of fresh PMA. 
Finally,  we  found  that the  natural  PKC  activator,  diacyl- 
glycerol,  caused  a  30%  inhibition  of internalization.  The 
rapid  hydrolysis  and  removal  of diacylglycerol  from the 
cytosol of intact cells is probably responsible for the lack of 
complete inhibition  (18).  In contrast to these  results,  the 
PKC inhibitors staurosporine, H-7, and calphostin C did not 
reverse the effects of PMA on folate uptake. Each inhibitor 
was used at a concentration substantially lower than that re- 
quired for a complete inhibition of PKC to maintain cell via- 
bility (7, 33). Thus, although we can not entirely rule out the 
possibility that proteins other than PKC are the principle 
Smart et al. Inhibition of Potocytosis  309 Figure 5.  PMA inhibits the internalization of caveolae in MA104 cells (A and B) and NIH 3T3 cells (C and D). Both sets of cells were 
incubated in the presence  (B and D) or absence (A and C) of 1 #M PMA for 30 rain at 37°C. The cells were then chilled to 4°C  and 
incubated in the presence of either  100/~g/ml of rabbit anti-folate receptor IgG (A and B) or a 1:1 dilution of hybridoma culture media 
from cells producing anti-Thy-1 IgG (C and D) for 1 h at 4°C. The cells were then processed for indirect immunogold localization of bound 
IgG. Black arrows mark the clusters of gold while the arrow heads indicate caveolae. Bar, 0.5/zm. 
effector of inhibition, the majority of the data supports a role 
for the kinase. 
PMA Inhibits the Invagination of Caveolae 
Previously, we showed that cholesterol-lowering drugs in- 
hibit folate internalization by reducing both the density of 
clustered folate receptors and the number of caveolae on the 
cell surface (9,  28).  To determine how PMA was affecting 
the plasma membrane, we incubated cells in the presence of 
1/zM PMA at 37°C and then chilled the cells to 4°C before 
using immunogold to localize folate receptors by electron 
microscopy (Fig. 5). Untreated MA104 cells (Fig. 5 A) had 
numerous clusters of anti-folate receptor IgG-gold and often 
they were associated with caveolae (Fig.  5 A, compare ar- 
rows with arrow heads). By contrast, PMA-treated cells had 
normal appearing gold clusters, but there was nearly a com- 
plete absence of caveolae (Fig. 5 B, compare arrows with ar- 
row heads).  Quantification of gold clusters and caveolae in 
the two sets of cells (Table I) showed that while PMA did not 
affect folate receptor clustering, there was a  10-fold reduc- 
tion in the number of visible caveolae. The number of caveo- 
lae  in  cells  that  were  incubated  in  the  presence  of 4c~- 
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the Distribution of  Anti-folate Receptor IgG-goM and on the 
Number of Invaginated Caveolae 
Number of 
Number of  Number of  labeled  Gold/ 
clusters  caveolae  caveolae  caveolae 
Control  214  174  108  3.81 
PMA  193  18  8  4.13 
Cells were prepared and processed for localization  of anti-folate  receptor IgG. 
Random pictures of each sample were taken at a  constant  magnification of 
10,800 × and quantification was carried out directly on the negative. The linear 
distance of membrane evaluated in 40 cells was 385/~m for control  and 380 
~m for PMA-treated cells. 
phorbol-12,13-didecanoate (PDD) were the same as control 
ceils (data not shown). 
These results suggested that PMA was preventing the up- 
take of pH]folic acid in MA104 cells by inhibiting the in- 
vagination of caveolae. We carried out exactly the same ex- 
periments on NIH 3T3 cells using anti-Thy-1 IgG-gold as a 
marker for GPI-anchored membrane proteins (Fig. 5, C and 
D).  Thy-1  was  clustered on the surface of both untreated 
(Fig. 5 C, arrows) and PMA-treated cells (Fig. 5 D, arrows). 
However, there was a nearly complete absence of caveolae 
in the treated cells (compare arrow heads in Fig. 5,  C and 
D).  Caveolae are organized into patches on the surface of 
3T3 cells (Fig. 5 C) and as a consequence, PMA treatment 
caused the individual clusters of anti-Thy-1  gold to merge 
into giant clusters of gold (Fig. 5 D, arrows). We also exam- 
ined  normal  human  fibroblasts  by both  thin  section and 
rapid-freeze, deep-etch electron microscopy. PMA appeared 
to cause the caveolae to flatten without disrupting the charac- 
teristic spiral coat (data not shown).  This is in agreement 
with the finding that PMA did not alter the surface distribu- 
tion of caveolin (data not shown). 
PMA Inhibits Receptor-mediated Potocytosis 
The function of the folate receptor is to concentrate 5-meth- 
yltetrahydrofolate and deliver it to cells by potocytosis (6). 
All of the biochemical and morphological evidence indicates 
that this process takes place in caveolae. The ability of PMA 
to inactivate caveolae offered the first opportunity to deter- 
mine directly if this organdie is involved in potocytosis. We 
depleted MA104 cells of endogenous folate and incubated 
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i  i  i  l  [  i  [ 
1  2  3  4  5  6  7 
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Figure 6. PMA prevented the 
delivery of 5-methyl[3H]tetra  - 
hydrofolic acid  to  the  cyto- 
plasm. Triplicate sets of  dishes 
were incubated either  in the 
presence  (m) or absence ([]) 
of 1 #M PMA for 30 min at 
37°C. 5-methyl[3H]tetrahydro  - 
folic acid (10 nM) was added 
directly to each dish and the 
incubation was continued for 
the  indicated times at 37°C. 
At the end of the incubation,  the cells  were chilled on ice for 
20 min and the amount of 5-methyl[3H]tetrahydrofolic  acid in the 
cytoplasm was determined by standard methods (22). 
0.5 hr 
2.0 hr 
2,0 hr + Probenecid 
Control  PMA 
J  i 
x 
x  x 
Figure 7.  PMA does not inhibit receptor-independent uptake of 
5-methylpH]tetrahydrofolic acid. Triplicate sets of dishes received 
1/,M 5-methyl[~H]tetrahydrofolic  acid and were incubated for the 
indicated times in the presence or absence of 10 mM probeneeid. 
The amount of 5-methyl[~H]tetrahydrofolic  acid in the cytoplasm 
was determined by standard methods. 
them in the presence (Fig. 6,  =) or absence (Fig. 6, []) of 
1 #M PMA for 30 rain before adding 10 nM 5-methylpH]- 
tetrahydrofolate to the dish and incubating for the indicated 
time. At each time point, the total cellular folate was mea- 
sured.  Control cells  accumulated 5-methylpH]tetrahydro- 
folate at a  normal rate of •1  pmol/mg of protein/h (21). 
PMA-treated  cells,  by  contrast,  did  not  accumulate  any 
5-methyl[3H]tetrahydrofolate during the incubation period. 
We noticed that there was a constant amount of 5-methyl- 
[3H]tetrahydrofolate  associated with PMA-treated cells (Fig. 
6,  PMA). Chromatographic  analysis  of the  radioactivity 
from these cells showed that all of the label was folylmono- 
glutamate (data not shown),  which indicates that it never 
reached the cytoplasm of the cell where polyglutamylation 
takes place (21). Virtually all of the label taken up by control 
ceils, on the other hand, was folylpentaglutamate. 
Once 5-methyltetrahydrofolate dissociates from the folate 
receptor within closed caveolae, it moves into the cell through 
an anion carder in the membrane (21). Micromolar concen- 
trations of the vitamin easily enter cells through this carder 
without the need of a folate receptor (21). We wanted to rule 
out the possibility that PMA was preventing uptake by block- 
ing this carrier. Therefore, we incubated treated and untreated 
cells in the presence of 1/zM 5-methyl[3H]tetrahydrofolate 
for 0.5 and 2.0 h (Fig. 7) and then measured the amount of 
cell-associated radioactivity. Fig. 7 shows that PMA had no 
effect on receptor-independent uptake of 5-methyl[3H]tetra  - 
hydrofolate. Probenecid, a general inhibitor of anion carders, 
blocked uptake in both sets of cells (Fig. 7). Finally, we de- 
termined  by liquid  chromatography that  the  cytoplasmic 
5-methyl[3H]tetrahydrofolate was polyglutamylated regard- 
less of whether or not the cells were treated with PMA (data 
not shown). 
Discussion 
Potocytosis is a special name that was selected to distinguish 
the uptake of small molecules and ions from the uptake of 
macromolecules by receptor-mediated endocytosis (16), be- 
cause entrance into the cell appeared to depend on caveolae 
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of potocytosis  inhibitors  that  work by  preventing  the  in- 
ternalization  of caveolae  reaffirms  the  uniqueness  of this 
pathway. 
Clathrin-coated  pits, lamellipodia, and caveolae are three 
regions of the plasma membrane that seem to be specialized 
for endocytosis (3). The only known way to inhibit endocy- 
tosis by coated pits and lameUipodia is to physically disrupt 
the structural  molecules that control invagination  and bud- 
ding (3,  17, 25,  31).  Endocytosis by caveolae seems to be 
different.  We previously showed that depletion of intracellu- 
lar cholesterol in MA104 cells selectively reduces the num- 
ber  of caveolae  (28)  and  causes  a  marked  inhibition  of 
potocytosis  (9).  In addition,  treatment  of purified plasma 
membranes with cholesterol-binding  drugs  such as  filipin 
causes invaginated  caveolae to become fiat (27). Therefore, 
potocytosis appears to be controlled by the lipid phase of the 
caveolar membrane. 
The effects of PMA and other PKC activators  help to fur- 
ther define how caveolae work. PMA inhibits folate receptor 
internalization  almost instantaneously, but allows the closed 
caveolae to open at a normal rate (Fig. 2). Electron micro- 
scopic observations (Fig. 5, B and D) show that the drug pre- 
vents the invagination  of the caveolar membrane. The curva- 
ture of coated pits is not affected (data not shown), which is 
consistent  with previous  studies  (7,  24,  33)  showing that 
receptor-mediated  endocytosis  is  not  inhibited  by  PMA. 
PMA may have its effect by directly or indirectly controlling 
the invagination process. The profound dependence of caveo- 
lae architecture  on cholesterol suggests that a candidate  tar- 
get for PMA is an enzyme involved in membrane lipid me- 
tabolism. PMA is known to affect both the biosynthesis and 
the hydrolysis of phospholipids (23). 
There are  several  reasons  to  suspect  that  PMA  has  its 
effects on caveolae by activating  PKC:  inhibition was rapid 
and occurred at nanomolar concentrations of the drug; cav- 
eolae were no longer inactivated  after over night incubation 
in the presence of PMA; PKC activators that are structurally 
unrelated to PMA were equally effective; inactive isomers of 
these PKC activators had no effect on folate uptake. The PKC 
family of isoenzymes are generally recognized to be kinases 
that control different signal-transducing  pathways (18).  Nor- 
really these kinases are activated  by extraceUular  signaling 
ligands  such  as hormones,  growth  factors,  and cytokines 
(18). We now must consider the possibility that these ligands 
sometimes exert their effects on cells by controlling caveolae 
internalization  (4). For example, methacholine-induced Ca  2+ 
oscillations  in  mouse  lacrimal  acinar  cells  appear  to  be 
caused by periodic fluctuations in PKC activity (8). Caveolae 
contain both an IPrregulated Ca  2+ channel and a Ca  2+ ATP- 
ase.  If sinusoidal changes in Ca  ~+ influx and efflux depend 
on the cyclic opening and closing of caveolae, then activated 
PKC would inhibit Ca  2+ oscillations. Many  of the early ef- 
fects that PMA has on cells may ultimately be traced to the 
inhibition of potocytosis. 
PMA, as well as other activators of PKC, is a new tool for 
studying the potocytosis of small molecules and ions. These 
reagents  should be useful for identifying other llgands that 
are internalized by this route.  In addition, they should help 
us determine the molecular basis of caveolar internalization 
because the controlling molecule(s)  may be substrates  for 
PKC. 
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